  Different convolutional neural network (CNN) models have been tested for
their application in histological image analyses. However, these models are
prone to overfitting due to their large parameter capacity, requiring more data
or valuable computational resources for model training. Given these
limitations, we introduced a novel architecture (termed PlexusNet). We utilized
310 Hematoxylin and Eosin stained (H&E) annotated histological images of
prostate cancer cases from TCGA-PRAD and Stanford University and 398 H&E whole
slides images from the Camelyon 2016 challenge. PlexusNet-architecture -derived
models were compared to models derived from several existing "state of the art"
architectures. We measured discrimination accuracy, calibration, and clinical
utility. An ablation study was conducted to study the effect of each component
of PlexusNet on model performance. A well-fitted PlexusNet-based model
delivered comparable classification performance (AUC: 0.963) in distinguishing
prostate cancer from healthy tissues, although it was at least 23 times
smaller, had a better model calibration and clinical utility than the
comparison models. A separate smaller PlexusNet model accurately detected
slides with breast cancer metastases (AUC: 0.978); it helped reduce the slide
number to examine by 43.8% without consequences, although its parameter
capacity was 200 times smaller than ResNet18. We found that the partitioning of
the development set influences the model calibration for all models. However,
with PlexusNet architecture, we could achieve comparable well-calibrated models
trained on different partitions. In conclusion, PlexusNet represents a novel
model architecture for histological image analysis that achieves classification
performance comparable to other models while providing orders-of-magnitude
parameter reduction.
